This topic contains a solution. Click here to go to the answer

Author Question: Motivation in purchasing common grocery products a. is always high. b. is often low. c. is high ... (Read 63 times)

abc

  • Hero Member
  • *****
  • Posts: 543
Motivation in purchasing common grocery products
 a. is always high.
  b. is often low.
  c. is high for frequently purchased items, but low for durables.
  d. is low for coupon users, but high for others.
  e. is always high in Western Europe and the United States, but is low elsewhere.

Question 2

Shelly did not take much time to make a decision about her toothpaste. She looked to see if either of the two brands she regularly bought was on sale and then tossed the cheaper one into her shopping cart. Shelly's ____ in choosing toothpaste.
 a. ability is low
  b. risks are high
  c. motivation is high
  d. opportunity is low
  e. motivation is low



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vseab

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

B

Answer to Question 2

E




abc

  • Member
  • Posts: 543
Reply 2 on: Jun 28, 2018
Thanks for the timely response, appreciate it


nyrave

  • Member
  • Posts: 344
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Malaria was not eliminated in the United States until 1951. The term eliminated means that no new cases arise in a country for 3 years.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library